California‑based Exin Therapeutics Inc. plans to invest ₱1.45 billion to develop the Philippines’ first neurotherapeutics laboratory in Taguig and Clark .
The Board of Investments granted “green lane” certification to speed approvals . The lab will combine gene‑therapy research with AI‑driven drug discovery; its first phase will process 10 drug candidates monthly and aims to create 35 high‑value jobs for Filipino scientists .